Three-Dimensional Structural Modelling and Calculation of Electrostatic Potentials of HLA Bw4 and Bw6 Epitopes to Explain the Molecular Basis for Alloantibody Binding: Toward Predicting HLA Antigenicity and Immunogenicity : Transplantation

Journal Logo

Original Basic Science

Three-Dimensional Structural Modelling and Calculation of Electrostatic Potentials of HLA Bw4 and Bw6 Epitopes to Explain the Molecular Basis for Alloantibody Binding

Toward Predicting HLA Antigenicity and Immunogenicity

Mallon, Dermot H.1; Bradley, J. Andrew1; Winn, Peter J.2; Taylor, Craig J.3; Kosmoliaptsis, Vasilis1

Author Information
Transplantation 99(2):p 385-390, February 2015. | DOI: 10.1097/TP.0000000000000546
  • Free

Background 

We have previously shown that qualitative assessment of surface electrostatic potential of HLA class I molecules helps explain serological patterns of alloantibody binding. We have now used a novel computational approach to quantitate differences in surface electrostatic potential of HLA B-cell epitopes and applied this to explain HLA Bw4 and Bw6 antigenicity.

Methods 

Protein structure models of HLA class I alleles expressing either the Bw4 or Bw6 epitope (defined by sequence motifs at positions 77 to 83) were generated using comparative structure prediction. The electrostatic potential in 3-dimensional space encompassing the Bw4/Bw6 epitope was computed by solving the Poisson-Boltzmann equation and quantitatively compared in a pairwise, all-versus-all fashion to produce distance matrices that cluster epitopes with similar electrostatics properties.

Results 

Quantitative comparison of surface electrostatic potential at the carboxyl terminal of the α1-helix of HLA class I alleles, corresponding to amino acid sequence motif 77 to 83, produced clustering of HLA molecules in 3 principal groups according to Bw4 or Bw6 epitope expression. Remarkably, quantitative differences in electrostatic potential reflected known patterns of serological reactivity better than Bw4/Bw6 amino acid sequence motifs. Quantitative assessment of epitope electrostatic potential allowed the impact of known amino acid substitutions (HLA-B*07:02 R79G, R82L, G83R) that are critical for antibody binding to be predicted.

Conclusions 

We describe a novel approach for quantitating differences in HLA B-cell epitope electrostatic potential. Proof of principle is provided that this approach enables better assessment of HLA epitope antigenicity than amino acid sequence data alone, and it may allow prediction of HLA immunogenicity.

HLA mismatched allografts commonly provoke alloantibody responses directed against polymorphic amino acid motifs (B-cell epitopes) on the surface of donor HLA glycoproteins. Such B-cell responses are often refractory to conventional immunosuppressive agents and are a major cause of chronic graft rejection. The alloantibody response in recipients of grafts with multiple HLA mismatches is usually directed against a small number (typically 1 or 2) of immunodominant epitopes.1,2 However, because polymorphic HLA molecules have evolved from common ancestral HLA types, many epitopes are shared by different HLA specificities resulting in a high degree of serological cross-reactivity. For a potential transplant recipient with a given HLA type, the ability to predict the relative immunogenicity to different HLA alloantigens would enable a more rational approach to donor selection, thereby avoiding HLA mismatches most likely to evoke a strong alloantibody response.

The immunogenicity of HLA class I and class II mismatches can be predicted by interlocus subtraction of amino acid sequence motifs (triplets and eplets) that define immunogenic epitopes associated with alloantibody production and renal transplant outcome.3-5 However, defining epitopes based on amino acid sequence comparison alone provides an incomplete description of the immunogenicity of an epitope. The specificity and affinity of antibody-antigen interactions are largely governed by electrostatic forces dictated by the number and distribution of charged atoms on the surface of the HLA molecule.6-8 Moreover, amino acid polymorphisms outwith an epitope may alter its tertiary structure and electrostatic pattern.9 Consequently, epitopes with an identical amino acid sequence expressed on different HLA molecules may present widely differing electrostatic patterns because of topographical alterations imposed by distant amino acid polymorphisms.9 Conversely, common structural electrostatic motifs may be conserved between HLA molecules despite variation in the amino acid sequence motif because of conservative amino acid substitutions with side chains that have similar physiochemical properties.

We have previously used atomic resolution structural modelling to define the surface electrostatic potential of HLA class I molecules in order to understand better the molecular basis for alloantibody binding epitopes and to predict their relative ability to evoke a humoral response.9 This approach provided novel qualitative insights into the heterogeneity of HLA-specific antibody binding that could not be explained by amino acid sequence comparisons alone. We have now applied methods to quantitatively assess differences in the surface electrostatic patterns of HLA molecules, and here we report our analysis of the 2 common HLA class I epitopes, Bw4 and Bw6, that are serologically well-characterized with known amino acid sequence motifs.

MATERIALS AND METHODS

Generation of Structural and Physiochemical Models of HLA Class I Molecules

HLA class I structures, resolved using X-ray crystallography with a resolution of less than 1.5Å (Protein Data Bank codes: 1K5N, 1X7Q, 1XH3, 2BVP, 3BWA, 3LN4, 3MRE, 3SPV), were used as templates to generate atomic resolution 3-dimensional structural models of common HLA-A and HLA-B alleles that express the Bw4 or Bw6 epitope, as previously described.9 HLA allele sequence data was retrieved from the Immunogenetics/HLA database (ftp.ebi.ac.uk/pub/databases/ipd/imgt/hla). Mean sequence homology between templates and target sequences was 91.9% (range, 84.1% to 100.0%). Because electrostatic forces are a critical determinant of antibody-antigen interaction, the electrostatic potential above the molecular surface of each HLA allele modelled was calculated.10 To standardize the peptide binding groove environment, all HLA class I structures were modelled with an alanine nonamer peptide. In brief, homology modelling was performed using the MODELLER computer algorithm (https://salilab.org/modeller/)11 and the stereochemical quality of each model confirmed using Ramachandran plots,12 DOPE,13 Verify3D14 and WHAT_CHECK15 scores. Atom charges and radii were assigned and side-chains protonated for pH 7.4 using the PARSE force-field in PDB2PQR.16 The electrostatic potential in 3-dimensional space of each HLA class I model was calculated by solving the linearized Poisson-Boltzmann equation in Advanced Poisson Boltzmann Solver (http://www.poissonboltzmann.org/)10 for a cubic grid with sides of 353 points at a spacing of 0.33Å (Figure 1). Other parameters were set as follows: ionic solution of 0.15M of univalent positive and negative ions, protein dielectric of 2, solvent dielectric of 78, temperature of 310K, and a probe radius of 1.4Å.

F1-30
FIGURE 1:
Schematic representation of the method used to quantitate the surface electrostatic potential of the Bw4 and Bw6 epitopes expressed on HLA class I molecules. The HLA class I molecule is depicted in gray and the Bw4 or Bw6 epitope is highlighted in color. A, Atomic resolution 3-dimensional structural models of common HLA-A and HLA-B alleles that express the Bw4 or Bw6 epitope were created. B, The electrostatic potential in the 3-dimensional space around each HLA class I model was calculated by solving the linearized Poisson-Boltzmann equation, as implemented in APBS, for a cubic grid with sides of 353 points spaced 0.33Å apart. C and D, To enable selective electrostatic potential comparison of the Bw4 and Bw6 epitopes, a virtual sphere of interest (10Å in radius) was created to encompass the canonical Bw4/Bw6 motif. Quantitative comparisons of the electrostatic potential of the Bw4/Bw6 epitope were made for each HLA allele by comparing electrostatic potential at analogous grid points within the sphere of interest.

Quantitative Comparison of 3-Dimensional Electrostatic Potential of the Bw4 and Bw6 Epitopes

Electrostatic potential comparisons were performed based on the method described by Wade et al17,18 (http://pipsa.eml.org/pipsa/). In brief, this method considers the electrostatic potential in a “skin” above the molecular surface of a protein and quantitative comparison is performed for grid points within the intersection of the “skins” of two superimposed proteins.18 For the purpose of this study, a “skin” of 4 Å thickness, raised 3Å above the molecular surface of HLA molecules, was defined. To enable selective comparison of Bw4 and Bw6 epitopes, a spherical region of interest was considered that encompasses the canonical Bw4/Bw6 sequence motif. The center of the sphere was defined as the geometric average of the position of the side chain atoms of amino acids 77 to 83, and a radius of 10Å was selected to encompass the Bw4/Bw6 residues of all superimposed HLA molecules. Electrostatic potential comparisons were made between grid points within the intersecting skins that were bounded by the sphere (Figure 1). This resulted in a median of 2640 grid point comparisons which were then used to calculate a similarity index (using the Hodgkin index18,19) for the 2 epitopes being compared. The Hodgkin index assigns values between 1 (electrostatic identity, both in magnitude and sign) and −1 (electrostatic anticorrelation of the sign of the potential but of the same magnitude), which were then converted into a distance (electrostatic similarity distance [ESD] [(2 − 2SI)½]) to give values between 0 (electrostatic identity) and 2 (electrostatic anticorrelation), where 1 represents no apparent correlation. The ESD was considered to 3 decimal places. For the purpose of this study, the electrostatic potential space overlaying the Bw4/Bw6 epitope was sampled using a sphere to identify relevant grid points; different approaches for sampling the electrostatic potential space (e.g., sphere radius of 8 to 12Å, using a cone instead of a sphere and sampling from a skin of variable thickness and distance from the molecular surface) did not alter the results of the quantitative epitope comparisons (data not shown).

Electrostatic potential comparisons were made for all possible combinations of common Bw4/Bw6-expressing HLA class I alleles studied (in a pairwise, all-versus-all fashion). The ESDs generated by the epitope comparisons were compiled as a distance matrix, which was then displayed as a symmetrical heatmap with reordering such that alleles with electrostatically similar epitopes cluster together. Symmetrical heatmaps and allele reordering were performed in R using complete linkage hierarchical clustering as implemented in the hclust function.20

RESULTS

A novel approach for comparing electrostatic potential was used to assess Bw4 and Bw6 epitope antigenicity. Quantitative assessment of the surface electrostatic potential of Bw4 and Bw6 epitopes was undertaken by placing a sphere of 10 Å radius over the epitope to identify the relevant grid points. Paired comparisons of epitope surface electrostatic potential were made for all possible combinations of the 50 common Bw4/Bw6-expressing HLA class I alleles, and the results, clustered according to ESD and depicted as a heatmap and dendrogram, are shown in Figure 2. When all alleles were compared, there was substantial heterogeneity in ESD ranging from 0.000 to 1.918 (from a possible range of 0.000 to 2.000) with 3 principal clusters, 2 of which contained exclusively Bw6-expressing alleles (clusters A and B) and a third cluster (cluster C) of Bw4-expressing alleles. Within the 3 clusters, there was further variation in ESD (cluster A, 0.000 to 1.441; cluster B, 0.063 to 0.195; cluster C, 0.000 to 0.989). Importantly, Bw4-expressing HLA-A alleles located appropriately within cluster C. The ability of ESD to segregate alleles expressing the serologically distinct Bw4 and Bw6 epitopes supports the concept that quantifying the 3-dimensional surface electrostatic potential of an epitope accurately reflects well-characterized antibody binding patterns. The 3 Bw6-expressing alleles that comprise cluster B (HLA-B*18:06, −B*46:01 and -B*73:01) are known not to bind Bw6 alloantibodies, and it is notable that their epitope has distinct electrostatic properties to all the other Bw6-expressing alleles.

F2-30
FIGURE 2:
Heatmap and dendrogram of Bw4/Bw6 epitope electrostatic potential similarity between HLA class I alleles. Epitope electrostatic potential comparisons were made for all possible combinations of common Bw4/Bw6-expressing HLA class I alleles (in a pairwise, all-versus-all fashion). The ESD generated by the epitope comparisons were compiled to form a distance matrix displayed as a symmetrical heatmap with reordering, such that alleles with electrostatically similar epitopes are clustered together. There was substantial heterogeneity in ESD ranging from 0.000 to 1.918, resulting in three principal clusters, two of which contained exclusively Bw6-expressing alleles (clusters A and B) and a third cluster (cluster C) of Bw4-expressing alleles. White squares represent electrostatic dissimilarity between two epitopes and darker shades of blue represent increasing similarity. The height of the dendrogram arms between a given allele pair is proportional to the electrostatic disparity of their epitopes.

We next extended the analysis to include HLA-B*07:02 alleles in which targeted point mutations have been introduced into the Bw6 epitope that have differing effects on Bw6-specific monoclonal antibody (mAb) binding21 (Figure 3). The substitution of asparagine for threonine at position 80 (B*07:02 N80T) does not affect Bw6 mAb binding.21 The HLA-B*07:02 N80 and HLA-B*07:02 T80 are both located in cluster A, indicating a limited effect of the mutation on Bw6 surface electrostatic potential. In contrast, substitution of arginine for glycine at position 79 (HLA-B*07:02 R79G), arginine for leucine at position 82 (HLA-B*07:02 R82L) and glycine for arginine at position 83 (HLA-B*07:02 G83R) resulted in abrogation of Bw6 mAb binding.21 These mutated HLA-B*07:02 molecules were displaced from the native HLA-B*07:02, present in cluster A, into cluster B reflecting marked alterations on epitope surface electrostatic potential.

F3-30
FIGURE 3:
Heatmap and dendrogram of Bw4/Bw6 epitope electrostatic potential similarity between HLA class I alleles including mutated HLA-B*07:02 molecules. Epitope electrostatic potential comparisons were performed for all possible combinations of Bw4/Bw6-expressing HLA class I alleles, including mutated HLA-B*07:02 molecules, in a pairwise, all-versus-all fashion. The symmetrical heatmap and dendrogram were created as described in Materials and Methods and the Figure 2 legend. The amino acid substitution at position 80 (B*07:02 N80T) did not affect Bw6 mAb binding and had a minimal effect on Bw6 epitope electrostatic potential. Amino acid substitutions leading to abrogation of Bw6 mAb binding (HLA-B*07:02 R79G, HLA-B*07:02 R82L, and HLA-B*07:02 G83R), highlighted in gray, resulted in marked alterations of epitope surface electrostatic potential.

DISCUSSION

There is increasing awareness of the importance of epitope-based HLA matching to offset the risk of humoral alloimmunity after renal transplantation. The major focus to date has been on amino acid sequence comparisons of donor and recipient HLA class I and II epitopes, and this approach provides a better assessment of immunological compatibility than conventional HLA matching.3,4,22 We have shown previously that incorporating a physiochemical analysis of HLA alloantigens further improves predictions of immunogenicity23-25 and that qualitative structural assessment of the electrostatic topography of HLA B-cell epitopes provides an explanation for serological patterns of HLA-specific antibody binding.9 In the present study, we have created atomic resolution molecular models of HLA class I and calculated the electrostatic potential on the 3-dimensional surface of two common B-cell epitopes, Bw4 and Bw6, and applied these to understand better the molecular basis for alloantibody binding. Importantly, the novel quantitative approach described here can be used to compare 3-dimensional surface electrostatic differences between HLA B-cell epitopes that may reflect their relative immunogenicity.

We chose to focus our proof of principle analysis on Bw4 and Bw6 because they are widely expressed on different HLA class I molecules and are serologically well-characterized with known amino acid sequence motifs. When we compared the 3-dimensional surface electrostatic potential of the carboxyl terminal of the α1 helix of HLA-A and HLA-B alleles (corresponding to the position of Bw4 and Bw6), we observed that alleles segregated according to their expression of either Bw4 or Bw6 epitopes, indicating that B-cell epitopes with common functional characteristics share similar 3-dimensional surface electrostatic properties. In addition, analysis of HLA-B alleles in which targeted point mutations have been introduced into the Bw6 epitope showed that quantitative assessment of B-cell epitope electrostatic potential accurately reflects the functional impact of critical and noncritical amino acid substitutions on antibody binding. These observations validate the concept that quantitative assessment of electrostatic potential of a B-cell epitope has functional relevance and provides insight into alloantibody-HLA interactions that are not explicable in terms of amino acid sequence data alone.

Our quantitative analysis revealed that 3 alleles expressing the Bw6 amino acid sequence motif had electrostatic properties distinct from those found on the majority of Bw6-expressing alleles. These alleles are known not to bind Bw6-specific monoclonal alloantibodies, and it is interesting therefore that the epitope they express has distinct electrostatic characteristics. Moreover, within the 2 major Bw4 and Bw6 clusters, there was further electrostatic heterogeneity. Electrostatic forces are key mediators of the affinity of antigen-antibody interactions, 6,8 and it is possible that such variation in electrostatic potential of the same B-cell epitope, when expressed on different HLA molecules, may be an important determinant for the functional outcome of antibody binding. This has obvious implications for understanding the clinical significance of HLA-specific antibodies in transplantation, and it will be important to investigate this by subjecting computational predictions of specific HLA-alloantibody interactions to in vitro experimental validation.

The interaction of antibody with antigen is a highly complex and dynamic process, and it is important to emphasize that modelling this interaction was not the focus of the present study. Instead, our aim was to provide a computational method for comparing the physiochemical characteristics of an epitope as expressed by different HLA class I alleles to predict antigenicity and potentially immunogenicity. We focused our attention on the Bw4/Bw6 epitope of HLA class I but acknowledge that the antibody binding “footprint” on the HLA molecule extends well beyond the “functional” epitope and that antibody/antigen interactions outwith an epitope may be important, particularly for stabilizing the antibody/antigen interaction.3,26,27 It is also important to note that in this study, an alanine nonamer was modelled in the binding groove. Alanine was selected because it does not impose electrostatic or steric effects enabling, therefore, accurate prediction of HLA structure and epitope comparison between different HLA molecules. In contrast to the critical importance of peptide for recognition by alloreactive T cells, there is limited evidence for the role of peptide on HLA-specific alloantibody binding.28 However, we acknowledge that certain peptides presented by the HLA class I molecule may have an effect on Bw4/Bw6 surface electrostatic potential, but this effect is likely to be limited; modelling this interaction would be complex and beyond the scope of this study. Finally, although protein electrostatic properties are the major determinant of antibody binding affinity, other physical properties of biomolecules, such as hydrophobicity, may also influence antibody binding and have only indirectly been taken into account in our analysis.29

In conclusion, the present study provides proof of concept that atomic resolution modelling and comparison of B-cell epitope 3-dimensional surface electrostatic potential provides a physiochemical explanation for serological patterns of antibody binding. The quantitative comparison of epitope electrostatic potential between different HLA alleles may provide a novel tool for predicting HLA antigenicity and immunogenicity.

REFERENCES

1. Oldfather JW, Anderson CB, Phelan DL, Cross DE, Luger AM, Rodey GE. Prediction of crossmatch outcome in highly sensitized dialysis patients based on the identification of serum HLA antibodies. Transplantation 1986; 42: 267–270.
2. Delmonico FL, Fuller A, Cosimi AB, et al. New approaches to donor crossmatching and successful transplantation of highly sensitized patients. Transplantation 1983; 36: 629–633.
3. Duquesnoy RJ. A structurally based approach to determine HLA compatibility at the humoral immune level. Hum Immunol 2006; 67: 847–862.
4. Duquesnoy RJ, Marrari M. HLAMatchmaker-based definition of structural human leukocyte antigen epitopes detected by alloantibodies. Curr Opin Organ Transplant 2009; 14: 403–409.
5. Kosmoliaptsis V, Bradley JA, Sharples LD, et al. Predicting the immunogenicity of human leukocyte antigen class I alloantigens using structural epitope analysis determined by HLAMatchmaker. Transplantation 2008; 85: 1817–1825.
6. Chong LT, Duan Y, Wang L, Massova I, Kollman PA. Molecular dynamics and free-energy calculations applied to affinity maturation in antibody 48G7. Proc Natl Acad Sci USA 1999; 96: 14330–14335.
7. Sinha N, Mohan S, Lipschultz CA, Smith-Gill SJ. Differences in electrostatic properties at antibody-antigen binding sites: implications for specificity and cross-reactivity. Biophys J 2002; 83: 2946–2968.
8. Lippow SM, Wittrup KD, Tidor B. Computational design of antibody-affinity improvement beyond in vivo maturation. Nat Biotechnol 2007; 25: 1171–1176.
9. Kosmoliaptsis V, Dafforn TR, Chaudhry AN, Halsall DJ, Bradley JA, Taylor CJ. High-resolution, three-dimensional modeling of human leukocyte antigen class I structure and surface electrostatic potential reveals the molecular basis for alloantibody binding epitopes. Hum Immunol 2011; 72: 1049–1059.
10. Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci USA 2001; 98: 10037–10041.
11. Eswar N, Webb B, Marti-Renom MA, et al. Comparative protein structure modeling using Modeller. Curr Protoc Bioinformatics 2006;Chapter 5:Unit 5 6.
12. Ramachandran GN. Protein structure and crystallography. Science 1963; 141: 288–291.
13. Shen MY, Sali A. Statistical potential for assessment and prediction of protein structures. Protein Sci 2006; 15: 2507–2524.
14. Luthy R, Bowie JU, Eisenberg D. Assessment of protein models with three-dimensional profiles. Nature 1992; 356: 83–85.
15. Hooft RW, Vriend G, Sander C, Abola EE. Errors in protein structures. Nature 1996; 381: 272.
16. Dolinsky TJ, Nielsen JE, McCammon JA, Baker NA. PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res 2004; 32(Web Server issue): W665–W667.
17. Blomberg N, Gabdoulline RR, Nilges M, Wade RC. Classification of protein sequences by homology modeling and quantitative analysis of electrostatic similarity. Proteins 1999; 37: 379–387.
18. Wade RC, Gabdoulline RR, De Rienzo F. Protein interaction property similarity analysis. Int J Quantum Chem 2001; 83: 122.
19. Hodgkin EE, Richards WG. Molecular similarity based on electrostatic potential and electric field. Int J Quantum Chem 1987; 32: 105–110.
20. R Core Team (2014). R: A language and environment for statistical computing. R Foundation for Statistical Computing Vienna, Austriahttp://wwwR-projectorg/.
21. Lutz CT, Smith KD, Greazel NS, et al. Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the alpha-1 helix. J Immunol 1994; 153: 4099–4110.
22. Duquesnoy RJ, Askar M. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. V. Eplet matching for HLA-DR, HLA-DQ, and HLA-DP. Hum Immunol 2007; 68: 12–25.
23. Kosmoliaptsis V, Chaudhry AN, Sharples LD, et al. Predicting HLA Class I alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms. Transplantation 2009; 88: 791–798.
24. Kosmoliaptsis V, Sharples LD, Chaudhry AN, Halsall DJ, Bradley JA, Taylor CJ. Predicting HLA class II alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms. Transplantation 2011; 91: 183–190.
25. Kosmoliaptsis V, Sharples LD, Chaudhry A, et al. HLA class I amino acid sequence-based matching after interlocus subtraction and long-term outcome after deceased donor kidney transplantation. Hum Immunol 2010.
26. Laver WG, Air GM, Webster RG, Smith-Gill SJ. Epitopes on protein antigens: misconceptions and realities. Cell 1990; 61: 553–556.
27. Duquesnoy RJ, Mulder A, Askar M, Fernandez-Vina M, Claas FH. HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes. Hum Immunol 2005; 66: 749–761.
28. Mulder A, Eijsink C, Kester MG, et al. Impact of peptides on the recognition of HLA class I molecules by human HLA antibodies. J Immunol 2005; 175: 5950–5957.
29. Jones S, Thornton JM. Principles of protein-protein interactions. Proc Natl Acad Sci USA 1996; 93: 13–20.
Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.